QALYs

Related by string. QALY * * QALY gained . per QALY gained *

Related by context. Frequent words. (Click for all words.) 72 QALY 57 CI -#.# 55 HbA1C 55 confidence interval #.#-#.# 54 % CI #.#-#.# [003] 54 HRQoL 54 HbA1c levels 54 % CI #.#-#.# [006] 53 mortality morbidity 53 HRQOL 53 placebo p 53 statistically significant p = 53 CI #.#-#.# [002] 52 HbA 1c 52 annualized relapse 52 sensitivity specificity 52 prevalences 52 biochemical recurrence 52 serum PSA 51 comorbidity 51 confidence interval CI 51 morbidity mortality 51 placebo p = 51 P = .# 50 pg ml 50 comorbidities 50 sd = 50 % CI #.#-#.# [007] 50 PSA velocity 50 glomerular filtration rate 50 nonadherence 50 % CI #.#-#.# [002] 50 comorbid conditions 50 serum sodium 50 univariate 50 hemoglobin A1c 50 MetS 50 serum concentrations 50 systolic BP 50 nonobese 50 oophorectomy 49 warfarin therapy 49 Secondary endpoints include 49 hippocampal volume 49 estimated glomerular filtration 49 nonsignificant 49 QoL 49 statistically significant p 49 multivariate analyzes 49 androgen deprivation 48 premenopausal breast cancer 48 nonoperative 48 left ventricular systolic 48 covariates 48 logistic regression 48 serum calcium 48 covariance 48 Secondary endpoints included 48 symptom severity 48 anticoagulation therapy 48 hip fracture 48 pg mL 48 chronic rhinosinusitis 48 coronary revascularization 48 LVEF 48 hemoglobin A1C 48 endarterectomy 48 glycated hemoglobin 48 Arch Intern Med 48 thromboembolism 47 birthweight 47 ADAS cog 47 Secondary endpoints 47 obese adolescents 47 lipid lowering therapy 47 IPSS 47 osteoporotic fracture 47 cardiorespiratory fitness 47 eGFR 47 CI = 47 proportional hazards 47 airflow obstruction 47 serum uric acid 47 antibiotic prescribing 47 perinatal mortality 47 univariate analysis 47 rehospitalization 47 mmol L 46 postoperative complications 46 hemodynamics 46 therapeutic regimens 46 NT proBNP 46 lung function 46 DAS# [002] 46 PSA screening 46 systemic embolism 46 p = 46 cardiometabolic risk 46 Main Outcome Measures 46 cardiovascular hospitalization 46 hyperbilirubinemia

Back to home page